7-aminocephem derivative compounds

US10308666B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10308666-B2
Application numberUS-201815920609-A
CountryUS
Kind codeB2
Filing dateMar 14, 2018
Priority dateDec 23, 2014
Publication dateJun 4, 2019
Grant dateJun 4, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure provides methods of making certain 7-aminocephem derivatives useful in the manufacture of cephalosporin antibiotic compounds.

First claim

Opening claim text (preview).

We claim: 1. A process for making a compound of the formula (II): comprising the steps of: (a) forming a reaction mixture comprising phosphorous pentachloride (PCl 5 ) and pyridine; (b) adding a compound of the formula (IIa) to the reaction mixture: (c) adding isobutyl alcohol; (d) adding a solvent comprising water; (e) adding ethyl acetate; and (f) obtaining the compound of the formula (II). 2. The process of claim 1 , wherein step (a) comprises: (1) combining PCl 5 and dichloromethane; and (2) adding pyridine. 3. The process of claim 2 , wherein step (1) comprises: (i) combining 2.0 equivalents PCl 5 and 6.0 volumes dichloromethane while maintaining the temperature below 30° C.; and (ii) adjusting the temperature to 10 to 30° C. and agitating. 4. The process of claim 2 , wherein step (2) comprises: (i) adjusting the temperature to −10 to −5° C.; (ii) adding 2.0 equivalents of pyridine while maintaining the temperature at −10 to 5° C.; and (iii) adjusting the temperature to −5 to 0° C. and agitating. 5. The process of claim 1 , wherein step (b) comprises: (1) adding 1.0 equivalent compound (IIa) to the reaction mixture of step (a) while maintaining the temperature of the mixture at −10 to 0° C.; and (2) stirring the mixture at −10 to 0° C. 6. The process of claim 5 , wherein the mixture of step (2) comprises ≤5.0% compound (IIa) relative to compound (II)+compound (IIa). 7. The process of claim 1 , wherein step (c) comprises: (1) adjusting the temperature of the mixture to −20 to −10° C.; (2) adding 2.0 volumes of isobutyl alcohol dropwise while maintaining the temperature of the mixture at −20 to 5° C.; and (3) agitating the mixture at −10 to 0° C. 8. The process of claim 1 , wherein step (d) comprises: (1) adding a solvent comprising water to the mixture of step (c) while maintaining the temperature of the mixture at −10 to 5° C.; (2) agitating the mixture at −5 to 5° C.; and (3) separating a lower organic phase from the mixture and collecting the lower organic phase. 9. The process of claim 8 , wherein the solvent comprising water is a mixture of ethanol and water. 10. The process of claim 8 , which further comprises: (4) adding dichloromethane to the mixture at −10 to 0° C.; (5) agitating the mixture at −10 to 0° C.; and (6) separating a lower organic phase from the mixture and collecting the lower organic phase. 11. The process of claim 1 , wherein step (e) comprises: (1) concentrating the organic phase to 4 to 5 volumes; (2) adjusting the temperature to −10 to −5° C.; (3) adding 2.1 volumes of ethyl acetate dropwise while maintaining the temperature of the mixture at −10 to −5° C.; and (4) agitating the mixture at −10 to 5° C. 12. The process of claim 11 , wherein step (e) further comprises: (5) observing the formation of a precipitate; (6) concentrating the organic phase to 4 to 5 volumes; (7) adjusting the temperature of the mixture to −10 to −5° C.; (8) adding 2.1 volumes of ethyl acetate while maintaining the temperature of the mixture at −10 to −8° C.; and (9) agitating the mixture at −10 to −5° C. 13. The process of claim 1 , wherein step (f) comprises: (1) centrifuging the mixture to produce a cake; and (2) collecting the cake. 14. The process of claim 13 , wherein step (f) further comprises: (3) adding 2.2 volumes of ethyl acetate; (4) adjusting the temperature to −10 to −5° C.; (5) agitating at −10 to −5° C.; (6) centrifuging to produce a cake; (7) collecting the cake; and (8) drying the cake at 5 to 20° C.

Assignees

Inventors

Classifications

  • C07D501/04Primary

    from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10308666B2 cover?
This disclosure provides methods of making certain 7-aminocephem derivatives useful in the manufacture of cephalosporin antibiotic compounds.
Who is the assignee on this patent?
Merck Sharp & Dohme
What technology area does this patent fall under?
Primary CPC classification C07D501/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).